Related Experiment Video
Updated: Mar 1, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Palliative Effects of Phenolic, Polysaccharide, and Lipid Extracts of Hulless Barley Grass on Acute Ulcerative
Zhiqian Wu1, Mingming Wang1, Xiaoning Liu1
1Department of Food Science & Technology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Hulless barley grass (HBG) is rich in bioactive compounds such as phenolics, polysaccharides, and lipids, and consequently possesses antioxidant, anti-inflammatory, and anti-tumor properties. However, which components contribute to its potential palliative effect on acute ulcerative colitis (AUC) is unknown. In this study, phenolics, polysaccharides, and lipids were extracted separately from HBG, and their antioxidant activities and effects on AUC in vivo were investigated. Compared to the polysaccharide/lipid extracts, phenolic extracts (HBGPE) had much higher antioxidant capacity, with 1,1-diphenyl-2-picrylhydrazyl radical (DPPH·) scavenging capacity of 1.34 ± 0.02 mmol Trolox/100 g. The HBGPE also significantly decreased the body weight loss and colonic condition of dextran sodium sulfate (DSS)-induced AUC mice. The strong anti-inflammatory effects of HBGPE led to a significant reduction in the degree of inflammatory cell infiltration, crypt structure disruption, and mucosal damage, and down-regulated the mRNA expression of tumor necrosis factor (Tnfα), interleukin-6 (Il6), and Il1b. In addition, HBGPE could reduce intestinal flora disorders. Both polysaccharide and lipid extracts led to little reduction in the colon inflammatory condition. This study confirmed that HBG extracts could inhibit inflammatory response, oxidative stress, and gut microbial imbalance, especially HBGPE, which indicated that HBG may have potential for application in dietary prevention of AUC.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

